A new vascular Endostaple: A technical description  by Trout, Hugh H. & Tanner, Howard M.
of the Endostaple should have a low profile. The purpose
of this paper is to describe an Endostapling system that, on
preliminary testing, meets these criteria.
TECHNICAL DESCRIPTION
The Endostaples are composed of either interwound
double coils of nitinol wire (0.007 in or 0.1778 mm diam-
eter) or stainless steel wire (0.0065 in or 0.1651 mm
diameter). The Endostaples are made of these two differ-
ent shape memory metals so that a similar metal
Endostaple can be chosen to avoid contact of dissimilar
metals when used with supported endografts made of
either nitinol or stainless steel. In the relaxed state the coils
are themselves coiled, as illustrated in Fig 1. The primary
coil of both Endostaples has an outer diameter of 0.038 in
(0.9652 mm), whereas the secondary coil of both has a
diameter of 0.135 to 0.150 in (3.43-3.81 mm).
When the Endostaples are loaded for delivery, six or
more are serially aligned about a 530 to 540 µm ultralow
hydroxyl, polyimide–coated optical fiber as shown, with
three Endostaples, in Fig 2. The energy source is a
Holmium:YAG laser; its particular wavelength vaporizes
hydroxyl groups within the subject tissue on contact.
The delivery system is inserted through a 13F –internal
diameter or larger insertion sheath (insertion sheaths are
traditionally identified by the size of the catheter they are
designed to accept). The delivery system is composed of an
outer catheter (13F outside diameter) that can be deflected
up to 100 degrees within a 15-mm artery and an inner
catheter that houses the optical fiber and overlying
Endostaples. For the treatment of endoleak or the preven-
tion of migration, the delivery system can be inserted
through an insertion sheath placed in a femoral artery and
angled into position within the aortic neck of a patient who
has already had an endograft inserted for treatment of an
abdominal aortic aneurysm (Fig 3). The inner catheter is
advanced so that its tip engages the endograft within the
A vascular Endostaple is a single attachment unit that
is delivered through the lumen of a blood vessel; it is used
to penetrate the entirety of the luminal structure to
increase the integrity of the structure or to secure an intra-
luminal prosthetic device to the full thickness wall of the
luminal structure. Examples of possible application of
Endostaples include the following: (1) sealing leaks
(“endoleaks”) of arterial blood flow between the aortic
neck wall and the endograft in patients with abdominal
aortic aneurysms being treated with endoluminal devices
to exclude aneurysms; (2) preventing subsequent migra-
tion of endografts that do not have full thickness attach-
ment at the proximal aortic neck attachment site; (3)
attaching unsupported prosthetic bifurcation grafts to the
proximal necks of abdominal aortic aneurysms; and (4)
attaching unsupported tube grafts proximally and distally
within the proximal and distal necks of abdominal aortic
aneurysms.
The desirable attributes of an aortic Endostapling sys-
tem include the following: (1) the insertion catheter
should be small and flexible; (2) the delivery catheter head
should be easily maneuvered; (3) the aortic wall should be
penetrated easily, regardless of the degree of aortic wall
calcification; (4) the Endostaple should resist dislodgment
both immediately after insertion and thereafter for the
entire life of the recipient; and (5) the intraluminal portion
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PRELIMINARY INVESTIGATION
A new vascular Endostaple: A technical description
Hugh H. Trout III, MD, and Howard M. Tanner, Washington, DC
Objective: The purpose of this report is to describe a new vascular Endostapling system.
Methods: The vascular Endostapling system can be passed through a 13F insertion sheath that is inserted through the
femoral artery. An optical fiber and overlying Endostaple will penetrate a previously inserted endoprosthesis and the
aortic wall at whatever points are desired. Once the optical fiber is withdrawn, the Endostaple assumes its preformed
shape and acts like a through-and-through wire suture. As tissue ingrowth proceeds, the long-term security and stabi-
lization of the coiled coil mechanism are likely to increase.
Conclusions: We think Endostaples can be useful in preventing endograft migration and in treating endoleak at the site
of the aortic neck–proximal endograft interface. (J Vasc Surg 2001;34:565-8.)
aortic neck and is then further advanced until the portion
of the outer catheter opposite the tip of the inner catheter
is compressing the aortic neck wall (Fig 4). The laser is
then turned on, and while the inner catheter remains fixed,
the optical fiber and overlying 14-mm-long Endostaple
(while aligned along the laser fiber) are advanced approxi-
mately 8 to 9 mm through the endograft and aortic wall
(Fig 5). The inner sheath and accompanying optical fiber
with the remaining overlying Endostaples are withdrawn
inside the outer catheter, and the ejected Endostaple is left
firmly attaching the endograft to the aortic wall (Fig 6).
Fig 7 is an enlarged view of an Endostaple attaching a por-
tion of prosthetic graft to the full thickness of an aortic
wall. Note that only one Endostaple coil remains within
the lumen, thus limiting its intraluminal profile to slightly
less than 1 mm. This version is but one of a number of con-
figurations that have been considered.1,2 A common
theme, however, is that the Endostaple, constructed in a
shape memory alloy or material having similar performance
characteristics, is introduced at the same time as the optical
fiber and deforms to increase pullout resistance once the
optical fiber is withdrawn.
PRELIMINARY FEASIBILITY EVALUATION
All prosthetic grafts tested, including those made of
polyester fiber (Dacron), expanded polytetrafluoroethylene,
and polyesters, are easily penetrated with minimal adjacent
graft damage by a relatively low-power laser ablation (< 10
W), as are highly calcified human explanted aneurysm walls.
The laser will not transect metal struts made of nitinol or
stainless steel. In acute feasibility experiments in sheep and
calves, lasting up to 48 hours, with only Endostaples used
for the proximal anastomosis, we have shown that a short-
segment Dacron graft can be securely anastomosed to the
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Fig 2. Three Endostaples aligned along a laser fiber.
Fig 3. Supported bifurcation endograft inserted to exclude
abdominal aortic aneurysm. Delivery system (shown) inserted
through insertion sheath. Note that insertion sheath in each of
Figs 3 through 7 has been omitted for clarity.
Fig 1. Endostaple in relaxed state.
thoracic aorta with minimal bleeding at the time blood flow
is restored and with the grafts remaining patent for the
duration of the experiment.
DISCUSSION
The use of Endostaples that fully penetrate the aortic
wall holds great promise in both the treatment of endoleak
at the aortic neck/proximal endograft anastomosis and
the prevention of migration (and subsequent reperfusion
of the aneurysm) of the endograft from its aortic neck
attachment site. The Endostaple that we describe acts as a
wire suture or rivet that can be inserted through a 13F
catheter and has the additional advantage of allowing tis-
sue ingrowth within the interstices of its coils so that the
security of the attachment increases as tissue ingrowth
occurs. This approach may overcome some of the prob-
lems of devices currently approved by the Food and Drug
Administration that are used for endograft repair of
abdominal aortic aneurysms.
Treat proximal endoleak and prevent endograft
migration. There are at least two major problems with
the current generation of endovascular repair devices used
for treatment of abdominal aortic aneurysms: migration
and endoleak, particularly at the graft-aortic neck anasto-
mosis.3 A variety of strategies have been used to avoid one
or both of these complications, including placing hooks
on the endografts, using outward radial forces to attach
self-expanding stent-grafts to the inner surface of the aor-
tic neck, using fully supported stents to provide a rigid
matrix with the intention that the graft would then not
migrate, using suprarenal attachment with uncovered
stent portions extending across the orifices of the renal
arteries, and, when endoleaks occur, using additional
stents or stented endografts to try to correct the underly-
ing defect. None of these strategies has been entirely suc-
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cessful.4 The biomedical engineering problems include the
high probability that radially expanding forces of endo-
grafts against the intimas of relatively short and frequently
diseased aortic necks are not likely to be a sufficiently
durable attachment mechanism. It seems likely that,
through the years after implantation, endograft migration
will be problematic for an unacceptable number of endo-
graft devices not attached to the full thickness of the aor-
tic neck wall. Data to date from all endograft devices
lacking full aortic wall penetration for proximal attach-
ment suggest that the potential for migration and late
endoleak continues for the life of the patient.5-7 Neck
dilatation, aneurysm shortening, or both8 can also be
destabilizing to the endograft. Hooks or other penetrating
Fig 4. Delivery catheter compressing endograft against aortic wall.
Fig 5. Laser fiber and overlying Endostaple inserted through
endograft and aortic wall.
Fig 6. Laser fiber and inner sheath withdrawn. Endostaple acts
as rivet.
means attached to the endograft add unwanted dimen-
sional bulk and may not penetrate a calcified aorta; indeed,
they may serve to hold the endograft away from the aor-
tic wall. It is possible that Endostaple placement through
the full thickness of the aortic wall will be a remedy for
many, if not all, of these problems.
Other possible uses. Although it is entirely specula-
tive, a modular or sequential approach may allow the tube
portion of an unsupported bifurcation prosthetic graft to
be attached to the aortic neck with Endostaples with the
bifurcation limbs being attached to the iliac arteries with
stents or stent-grafts. Such an approach offers a number of
possible advantages. First, because the graft has no sup-
port struts or attachment hooks, the insertion sheath can
be smaller and more flexible and may thus be passed
through smaller, moderately diseased, and more tortuous
iliac arteries. Second, the attachment is more secure than
with stented endografts because the Endostaple provides
full thickness aortic wall attachment. Third, an endoleak
can be treated more easily with the addition of more
Endostaples without concern that the rigidity of a stented
graft might prevent apposition of the graft to an eccentric
aortic neck. Fourth, the unsupported nature of the graft
allows postoperative contraction of the aortic aneurysm
without adverse consequences. Finally, approximately 50%
of all patients with an abdominal aortic aneurysm are cur-
rently thought to be eligible for endograft placement. The
remaining 50% are excluded because of anatomical con-
siderations (angulated, short-diameter, or large-diameter
aortic necks; narrowed or aneurysmal iliac arteries). An
endovascular approach that can be used in these currently
excluded patients because of the greater security of the
graft attachment to the aortic neck in some of these set-
tings may substantially increase the number of patients
with abdominal aneurysm eligible for an endovascular
approach.
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Fig 7. Endostaple holding endograft against aortic wall.
